Mouse CytokeRatin 10 / KeRatin K10 Monoclonal Antibody

Mouse anti CytokeRatin 10 / KeRatin K10

Cat. Num. AAA570114

• Reactivity: Canine, Human, Mouse, Rat, Swine, Zebrafish
• Applications: Flow Cytometry, Immunocytochemistry, Immunohistochemistry, Immunohistochemistry, Western Blot
• Synonyms: CytokeRatin 10 / KeRatin K10; Monoclonal Antibody; Mouse anti CytokeRatin 10 / KeRatin K10; anti-CytokeRatin 10 / KeRatin K10 antibody

• Host: Mouse
• Reactivity: Canine, Human, Mouse, Rat, Swine, Zebrafish
• Clonality: Monoclonal
• Isotype: IgG1
• Clone Number: RKSE60
• Specificity: RKSE60 reacts exclusively with cytokeRatin 10 which is present in keRatinizing stRatified epithelia and in differentiated areas of highly differentiated squamous cell carcinomas.
• Form/Format: Each vial contains 100 ul 1 mg/ml purified monoclonal antibody in PBS containing 0.09% sodium azide.

• Applicable Applications for anti-CytokeRatin 10 / KeRatin K10 antibody: Flow Cytometry (FC), Immunocytochemistry (IHC), Immunohistochemistry (IHC) (frozen), Western Blot (WB)
• Application Notes: RKSE60 is suitable for immunoblotting, immunocytochemistry, immunohistochemistry on frozen tissues and flow cytometry. Optimal antibody dilution should be determined by titRation; recommended range is 1:100 - 1:200 for flow cytometry, and for immunohistochemistry with avidin-biotinylated Horseradish peroxidase complex (ABC) as detection reagent, and 1:100 - 1:1000 for immunoblotting appliCations.
• Source Note: RKSE60 is a Mouse monoclonal IgG1 antibody derived by fusion of SP2/0 Mouse myeloma cells with spleen cells from a Mouse immunized with cytokeRatins from the Human epidermis.
• Preparation and Storage: Store at 4 degree C, or in small aliquots at -20 degree C.

Testing Data

(Figure 1: Immunohistochemistry on frozen section of swine skin: positive staining of the keratinizing layer )

Testing Data

(Figure 2: Immunohistochemistry on frozen section of swine skin: positive staining of the keratinizing layer (higher magnification compared to figure 1) )

Testing Data

(Figure 3: Immunohistochemistry on paraffin section of human skin )

Testing Data

(Figure 4: Immunofluorescence staining of a 7 days old zebrafish embryo )

Related Product Information for anti-CytokeRatin 10 / KeRatin K10 antibody

CytokeRatins are a subfamily of intermediate filament proteins and are characterized by a remarkable biochemical diversity, represented in Human epithelial tissues by at least 20 different polypeptides. They range in molecular weight between 40 kDa and 68 kDa and isoelectric pH between 4.9 - 7.8. The individual Human cytokeRatins are numbered 1 to 20. The various epithelia in the Human body usually express cytokeRatins which are not only characteristic of the type of epithelium, but also related to the degree of matuRation or differentiation within an epithelium. CytokeRatin subtype expression patterns are used to an increasing extent in the distinction of different types of epithelial malignancies. The cytokeRatin antibodies are not only of assistance in the differential identification of tumors using immunohistochemistry on tissue sections, but are also a useful tool in cytopathology and flow cytometric assays.

Product Categories/Family for anti-CytokeRatin 10 / KeRatin K10 antibody

Cytoskeletal; Cell differentiation; Cytoskeleton

References

Ramaekers, F. C., Puts, J. J., Moesker, O., Kant, A., Huysmans, A., Haag, D., Jap, P. H., Herman, C. J., and Vooijs, G. P. (1983). Antibodies to intermediate filament proteins in the immunohistochemical identifiCation of Human tumours: an overview, Histochem J 15, 691-713. Puts, J. J., Moesker, O., Kenemans, P., Vooijs, G. P., and Ramaekers, F. C. (1985). Expression of cytokeRatins in early neoplastic epithelial lesions of the uterine cervix, Int J Gynecol Pathol 4, 300-13. Broers, J. L., Carney, D. N., Klein Rot, M., Schaart, G., Lane, E. B., Vooijs, G. P., and Ramaekers, F. C. (1986). Intermediate filament proteins in classic and variant types of small cell lung carcinoma cell lines: a biochemical and immunochemical analysis using a panel of monoclonal and polyclonal antibodies, J Cell Sci 83, 37-60. Ramaekers, F., Huysmans, A., Schaart, G., Moesker, O., and Vooijs, P. (1987). Tissue distribution of keRatin 7 as monitored by a monoclonal antibody, Exp Cell Res 170, 235-49. Van Muijen, G. N., Warnaar, S. O., and Ponec, M. (1987). Differentiation-related changes of cytokeRatin expression in cultured keRatinocytes and in fetal, newborn, and adult epidermis, Exp Cell Res 171, 331-45. Bijman, J.T., Wagener, D.J.T., van Rennes, H., Wessels, J.M.C., Ramaekers, F.C.S. and van den Broek, P. (1987). Modulation of placental alkaline phosphatase activity and cytokeRatins in Human HN-1 cells by butyRate, retinoic acid, Catecholamines and histamine, Br. J. Cancer 56, 127-32. Van Erp, P.E.J., Rijzewijk, J.J., Boezeman, J.B.M., Leenders, J., de Mare, S., Schalkwijk, J., van de Kerkhof, P.C.M., Ramaekers, F.C.S. and Bauer, F.W. (1989). Flow Cytometric analysis of epidermal subpopulations from normal and psoriatic skin using monoclonal antibodies anti intermediate filaments, Am J Pathol 135, 865-70. Ramaekers, F., van Niekerk, C., Poels, L., Schaafsma, E., Huijsmans, A., Robben, H., Schaart, G., and Vooijs, P. (1990). Use of monoclonal antibodies to keRatin 7 in the differential diagnosis of adenocarcinomas, Am J Pathol 136, 641-55. Schaafsma, H. E., Ramaekers, F. C., van Muijen, G. N., Lane, E. B., Leigh, I. M., Robben, H., Huijsmans, A., Ooms, E. C., and Ruiter, D. J. (1990). Distribution of cytokeRatin polypeptides in Human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression, Am J Pathol 136, 329-43. Smedts, F., Ramaekers, F., Robben, H., Pruszczynski, M., van Muijen, G., Lane, B., Leigh, I., and Vooijs, P. (1990). Changing patterns of keRatin expression during progression of cervical intraepithelial neoplasia, Am J Pathol 136, 657-68. Franssen, M.E.J., Boezeman, J.B.M., van de Kerkhof, P.C.M. and van Erp, P.E.J. (2003). Monitoring hyperprolifeRative disorders in Human skin: flow cytometry of changing cytokeRatin expression, Cytometry Part B (Clinical Cytometry) 57B, 32-39.